Literature DB >> 10074902

Analysis of the degradation function of Mdm2.

M H Kubbutat1, R L Ludwig, A J Levine, K H Vousden.   

Abstract

Degradation of the p53 tumor suppressor protein has been shown to be regulated by Mdm2. In this study, we identify regions of Mdm2 that are not required for p53 binding but are essential for degradation. Mdm2 mutants lacking these regions function in a dominant negative fashion, stabilizing endogenous p53 in cells by interfering with the degradative function of the endogenous Mdm2. p53 protein stabilized in this way does not strongly enhance the expression of p21(Waf1/Cip1), the product of a p53-responsive gene, supporting the model in which binding of Mdm2 to the NH2-terminal domain of p53 inhibits interaction with other components of the basal transcriptional machinery. Interestingly, COOH-terminal truncations of Mdm2 that retain p53 binding but fail to mediate its degradation are also stabilized themselves. Because Mdm2, like p53, is normally an unstable protein that is degraded through the proteasome, this result suggests a direct link between the regulation of Mdm2 and p53 stability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074902

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  34 in total

1.  MdmX protects p53 from Mdm2-mediated degradation.

Authors:  M W Jackson; S J Berberich
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells.

Authors:  Ismael J Samudio; Seshagiri Duvvuri; Karen Clise-Dwyer; Julie C Watt; Duncan Mak; Hagop Kantarjian; Dajun Yang; Vivian Ruvolo; Gautam Borthakur
Journal:  Leuk Lymphoma       Date:  2010-05

3.  Ubiquitination and degradation of mutant p53.

Authors:  Natalia Lukashchuk; Karen H Vousden
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

4.  A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Authors:  Konstantinos Karakostis; Sivakumar Vadivel Gnanasundram; Ignacio López; Aikaterini Thermou; Lixiao Wang; Karin Nylander; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

5.  Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

Authors:  R Ravi; B Mookerjee; Z M Bhujwalla; C H Sutter; D Artemov; Q Zeng; L E Dillehay; A Madan; G L Semenza; A Bedi
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

6.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

Authors:  R Khosravi; R Maya; T Gottlieb; M Oren; Y Shiloh; D Shkedy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer.

Authors:  Ruozhen Hu; Guang Peng; Hui Dai; Eun-Kyoung Breuer; Katherine Stemke-Hale; Kaiyi Li; Ana M Gonzalez-Angulo; Gordon B Mills; Shiaw-Yih Lin
Journal:  Cancer Res       Date:  2011-08-18       Impact factor: 12.701

8.  Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.

Authors:  J D Weber; M L Kuo; B Bothner; E L DiGiammarino; R W Kriwacki; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

9.  MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.

Authors:  Kyounghyun Kim; Robert Burghardt; Rola Barhoumi; Syng-Ook Lee; Xinyi Liu; Stephen Safe
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

10.  A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.

Authors:  Diptee A Kulkarni; Alexei Vazquez; Bruce G Haffty; Elisa V Bandera; Wenwei Hu; Yvonne Y Sun; Deborah L Toppmeyer; Arnold J Levine; Kim M Hirshfield
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.